High ARISCAT Before Thoracic Surgery: What Should Actually Change?
A high ARISCAT score is a planning trigger, not a diagnosis. This case maps which decisions change when risk is confirmed high — before, during, and after thoracic surgery.
Clinical scenario
67-year-old man scheduled for video-assisted thoracoscopic lobectomy (VATS) for early-stage lung cancer. ARISCAT score 52 (high risk). Contributing factors: age (>50), SpO₂ 93% on room air, intrathoracic surgical site, expected duration >3 hours.
FEV₁ 62% predicted, stable. Non-productive cough, no recent infection, no acute exacerbation. The surgical team notes this is his best timing window for resection.
Why this matters
ARISCAT high risk is a planning trigger, not a reason to cancel
This patient has a score of 52 — above the high-risk threshold of 45. In the ARISCAT derivation cohort, PPC incidence at this level was 42%. The question is not whether to cancel; the question is what changes in the plan because of this score.
Separating modifiable from non-modifiable factors
The first step with any high ARISCAT score is to categorize the contributing factors. Non-modifiable factors define the baseline risk — they cannot be removed, but they can be planned for. Modifiable factors may be correctable before the procedure.
| ARISCAT factor | This patient | Modifiable? | Preoperative action |
|---|---|---|---|
| Age > 50 | Yes — 67 years | No | Optimize all modifiable factors; plan enhanced monitoring |
| SpO₂ below 96% | Yes — 93% | Partially | Review ABG; ensure inhaler therapy is current; check for reversible bronchospasm |
| Intrathoracic surgical site | Yes | No — procedure required | Confirm postoperative ICU/HDU bed before day of surgery |
| Duration > 3 hours | Yes | No — fixed by procedure | Brief team explicitly; plan for extended ventilatory support if needed |
| Recent infection, anemia, emergency | No | N/A | — |
When most risk factors are non-modifiable, the focus shifts to support design
In this patient, age, surgical site, and duration cannot be changed. They define the baseline risk. Optimize what can be changed — SpO₂ cause, inhaler therapy — then design the intraoperative and postoperative support around what cannot.
What changes intraoperatively
- Lung-protective ventilation — mandatory: tidal volume 6–8 mL/kg IBW, PEEP individualized to compliance and position; check driving pressure
- One-lung ventilation management — monitor driving pressure on the dependent lung; reduce tidal volume further if driving pressure approaches 15 cmH₂O
- Regional analgesia component — paravertebral block, erector spinae plane block, or thoracic epidural; reduces opioid requirements and supports earlier extubation and mobilization
- Neuromuscular blockade management — confirm full reversal (TOF ≥ 0.9) before extubation; residual block and poor respiratory reserve compound each other
- Extubation criteria — define before the case; consider whether HDU extubation monitoring is indicated rather than standard PACU
What changes postoperatively
- ICU or HDU bed — for intrathoracic surgery with high ARISCAT, a monitored bed should be confirmed before the day of surgery, not assumed
- Oxygen targets — return to the patient's own SpO₂ baseline (93% here), not population normal; avoid targeting SpO₂ ≥ 96% in a patient whose baseline was lower
- HFNC or NIV availability — define the escalation plan explicitly: at what threshold, who escalates, and where
- Postoperative ABG — at 1–2 hours post-extubation if chronic CO₂ retention is a concern
- Early physiotherapy — mobilization and incentive spirometry from day 1; this population carries the highest risk for secretion retention and atelectasis progression
- Analgesia continuity — if a regional catheter is placed, confirm the infusion is running before extubation
A high score does not mean the standard plan with extra oxygen
Adding supplemental oxygen postoperatively and monitoring in a standard ward bed is not a high-risk PPC plan. The ARISCAT score predicts risk — it does not automatically generate the right interventions. That requires explicit team communication, confirmed bed level, and a documented escalation threshold.
Related reading
- ARISCAT high risk: what actually changes?
How to translate a high composite score into specific perioperative planning.
- Lung-protective ventilation in non-ARDS surgical patients
Tidal volume, PEEP, driving pressure — what to set and why.
- Regional anesthesia as a pulmonary strategy
Thoracic surgery analgesic options and respiratory benefit.
- Postoperative hypoxemia: first interpretation after surgery
Escalation thresholds and management when desaturation begins post-extubation.
ARISCAT 52, VATS lobectomy. What changes in the perioperative plan?
- 1.Plan explicitly for ventilation, analgesia, postoperative monitoring, and escalation before the case✓ Recommended
ARISCAT 52 is not a notation in the chart — it is a trigger for explicit planning across all risk domains.
- 2.
SpO₂ 93% may be partially optimizable — check whether reversible bronchospasm or undertreated airflow obstruction is a contributor.
- 3.Proceed with standard anesthesia plan — the score is documented and surgery is necessary⚠ Not recommended
Standard plan is inadequate when ARISCAT ≥ 45 — the score predicts 42% PPC incidence and requires explicit preparation.
Teaching points
- ARISCAT high risk (score ≥ 45) predicts a 42% PPC incidence. A score this high is not a reason to cancel — it is a trigger to plan ventilation, analgesia, postoperative monitoring, and escalation explicitly.
- Separating modifiable from non-modifiable factors is the first step. Age, surgical site, and duration cannot be changed — they define the baseline. Optimize what can be changed, and design support around what cannot.
- Thoracic surgery adds major procedure-related pulmonary risk on top of patient factors. One-lung ventilation, chest wall disruption, and resection all directly impair postoperative respiratory mechanics and reserve.
- High ARISCAT does not automatically generate the right perioperative plan. The anesthesiologist must design it: confirmed ICU/HDU bed, postoperative SpO₂ target relative to the patient's own baseline, HFNC/NIV availability, early physiotherapy, and a defined escalation threshold.
- Risk cannot be eliminated in this patient — what can be designed is the system of support: how to protect the lung intraoperatively, how to support it postoperatively, and when to escalate before reserve is exhausted.
Next clinical question
This patient is post-VATS lobectomy and desaturates in the PACU. SpO₂ 89% on room air, drowsy, shallow breathing. What is the first interpretation?
Case: Postoperative desaturation in PACU →Apply this in practice
Calculate the full ARISCAT score for this patient and review the management plan
ARISCAT Calculator →Continue learning
Preoperative SpO₂ 92% in an older patient: what should you do next?
A case-based walkthrough of how to interpret low preoperative SpO₂ and what steps to consider before surgery.
PaCO₂ 50 with elevated HCO₃⁻: how should you interpret possible chronic hypercapnia?
A case-based walkthrough of chronic compensated hypercapnia — how to distinguish it from acute respiratory acidosis, and what it means for perioperative and extubation planning.
TOF ratio 0.88 before extubation in a patient with chronic hypercapnia: what are the main concerns?
Two independent risks — residual neuromuscular block and chronic CO₂ retention — overlap before extubation. A case on why neither is safe to ignore, and what to check before the tube comes out.